In agreement with the excellent inhibition of S100B/p53, complex 44 demonstrated excellent cytotoxicity in A375 melanoma cells in a nanomolar concentration range (26.4 nM), as well as marked efficacy in B16F10 and A375 melanoma in vivo models. This evidence concerns the gene TP53 and melanoma.